Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 153 results found. Search for [ Adar Poonawalla coronavirus vaccine ]

Results 1 to 21 of 153
BusinessToday.In
November 29, 2020
India to develop vaccines for 60 percent of developing nations; 24 manufacturing units among 19 firms to develop vaccine in India: Bhargava


BusinessToday.In
November 29, 2020
Poonawallathanks PM Modi for visiting the institute; says SII shares his vision and continues to work towards ensuring a safe and secure India. SII may apply for emergency use authorisation of its vaccine in the next two weeks


BusinessToday.In
November 29, 2020
As coronavirus cases continue to rise, the UK plans to move fast in the approval process and clearance to Pfizer and BioNTech SE could come by next week


BusinessToday.In
November 29, 2020
Serum Institute of India's (SII) CEO Adar Poonawalla made the announcement hours after a meeting with Prime Minister Narendra Modi, who visited Serum's plant in Pune on Saturday, November 28


PB Jayakumar
November 28, 2020
Serum Institute will have a capacity to make over 2.5 billion doses of vaccines a year as it is currently upscaling the capacity from over 1.6 billion doses  


BusinessToday.In
November 28, 2020
PM Modi paid his visit to Pune-based Serum Institute of India and reviewed the manufacturing process of COVID-19 vaccine. He interacted with scientists at the SII and went around the facility, taking stock of vaccine development work


BusinessToday.In
November 27, 2020
After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon


PTI
November 26, 2020
The company had signed an MoU with the Uttar Pradesh government in December 2018 for Rs 5,000-crore investment in Noida and other cities in the state. It has committed to completing the project by 2025


BusinessToday.In
November 26, 2020
SII has partnered with AstraZeneca and Oxford University for the manufacturing and distribution of its COVID-19 vaccine candidate 'Covishield' in India and other countries


BusinessToday.In
November 24, 2020
The researchers said they could not explicate why the half dose manifested better protection, but added it may be that it prompts the immune system differently


BusinessToday.In
November 24, 2020
Advertisement created a stir because COVID-19 vaccine is yet to be rolled out for masses, and Centre is working on a distribution system once vaccine is available


BusinessToday.In
New Delhi, November 24, 2020
Former Reserve Bank of India's (RBI) governor Raghuram Rajan and deputy governor Viral Acharya have said that the proposals put out by an internal working group (IWG) of the central bank to allow corporate entry into banking is a \"bad idea.\"; Software giant Microsoft has rolled out a new feature on its Teams app through which up to 300 participants will be able to do free voice or video calls all day; Biotechnology major Biocon on Monday said it has inked an agreement for the acquisition of 26% stake on a fully diluted basis in Hinduja Renewables Two Pvt Ltd for Rs 5.91 crore. Watch this and more on News Blast.Also Read: 'India, top priority': Serum Institute CEO Adar Poonawalla on COVID-19 vaccine distribution plan


BusinessToday.In
November 24, 2020
Serum Institute has tied up with British-Swedish pharmaceutical firm AstraZeneca and the University of Oxford to mass-produce the Covishield vaccine to fight back COVID-19 virus


BusinessToday.In
November 23, 2020
Earlier on Monday, the Oxford-AstraZeneca team announced that one of the dosing regimens of the vaccine might be 90% effective in preventing COVID-19 infection


BusinessToday.In
November 23, 2020
Vaccine can be easily manufactured, transported and stored at domestic fridge temperature (2-8 degrees C). This means it can be easily distributed using existing medical facilities such as doctor's surgeries and local pharmacies, allowing for the vaccine to be deployed very rapidly, said Oxford University


BusinessToday.In
November 23, 2020
Coronavirus vaccine update: Adar Poonawalla, the CEO of Serum Institute had recently said that his company might sell a two-shot COVID-19 vaccine for around Rs 500-600 for the general public


BusinessToday.In
November 20, 2020
The current predicament of Delhi has also garnered the attention of the Health Ministry, which said the spike in daily new COVID-19 cases and fatalities in Delhi are having a spillover effect in the NCR regions of Haryana and Rajasthan


Rukmini Rao
November 20, 2020
E-commerce is blurring lines between online and offline with faster digitisation, says Amazon India head Amit Agarwal


BusinessToday.In
November 20, 2020
However, other schools across Maharashtra that don't come under BMC jurisdiction will reopen on November 23.


BusinessToday.In
November 20, 2020
The researchers said that COVID-19 infection rates between March and August across 15 countries, including UK, France, Italy, and Belgium were on an average 6.2 times higher than the reported cases


PAGES 1 OF 8  12345